Related Experiment Video
Updated: May 15, 2026

A RAPID Method for Blood Processing to Increase the Yield of Plasma Peptide Levels in Human Blood
Published on: April 28, 2016
Peptides binding to the hunger hormone ghrelin
M Vodnik1, P Molek, B Strukelj
1Department of Pharmaceutical Biology, Faculty of Pharmacy, Ljubljana, Slovenia. miha.vodnik@ff a.uni-lj.si
Neutralizing ghrelin, an appetite-stimulating hormone, offers a new obesity treatment. Researchers identified specific peptides, like MEMKKTHPVLGA, that bind to ghrelin, showing promise for drug development.
Area of Science:
- Biochemistry
- Pharmacology
- Molecular Biology
Background:
- Ghrelin is the primary peripheral orexigenic hormone, making its neutralization a potential obesity treatment strategy.
- Developing effective pharmacological interventions for obesity requires identifying molecules that can specifically target ghrelin.
Purpose of the Study:
- To identify and select peptides with high affinity for ghrelin using phage display technology.
- To evaluate the specificity and binding characteristics of selected peptides for potential therapeutic development.
Main Methods:
- Utilized random peptide phage display libraries (Ph.D.-7 and Ph.D.-12) for four selection procedures.
- Employed a stepwise elimination approach to remove non-specific binders and analyzed remaining clones via ELISA.
- Investigated binding properties, including specificity and interaction with ghrelin's N-terminal octanoyl group.
Main Results:
- Identified four phage-displayed peptides exhibiting moderate affinity for ghrelin.
- Peptides ADTVPRH and MEMKKTHPVLGA demonstrated the highest specificity among the selected binders.
- Peptide MEMKKTHPVLGA showed potential binding to the N-terminal octanoyl group crucial for ghrelin's receptor interaction.
Conclusions:
- Phage display is effective in identifying ghrelin-binding peptides.
- Peptide MEMKKTHPVLGA is a promising lead candidate for further investigation in the development of anti-obesity therapeutics.
- Targeting ghrelin, particularly its octanoylated form, represents a viable strategy for obesity pharmacotherapy.
Related Concept Videos
Regulation of Food Intake
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GPCRs Regulate Adenylyl Cylase Activity
Two...
Hormonal Regulation
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Insulin: The Receptor and Signaling Pathways

